NCT06359431 A Novel Smart Speculum Versus a Standard Speculum for Easy Visualisation of the Cervix and Performing Remote Cervical Cancer Screening Status NOT_YET_RECRUITING Phase NA
NCT06358053 CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers Status NOT_YET_RECRUITING Phase PHASE1
NCT06353061 Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer Status RECRUITING Phase PHASE2
NCT06351228 Fertility-sparing in Early-stage Cervcial Cancer: The ETERNITY Project Status NOT_YET_RECRUITING Phase N/A
NCT06333821 A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma Status NOT_YET_RECRUITING Phase PHASE3
NCT06315257 A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients Status RECRUITING Phase PHASE1
NCT06304610 Hospital-based Validation of the New ELEVATE Screening Tool Status NOT_YET_RECRUITING Phase NA
NCT06297811 Myeloprotection With Trilaciclib in Pan-cancer Population Status NOT_YET_RECRUITING Phase PHASE2
NCT06293898 Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors Status RECRUITING Phase PHASE1
NCT06291311 Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants Status RECRUITING Phase N/A
NCT06289751 Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer Status RECRUITING Phase PHASE2
NCT06289062 Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer Status RECRUITING Phase PHASE2
NCT06288373 Neoadjuvant Chemoimmunotherapy Versus Concurrent Chemoradiotherapy for LACC Status RECRUITING Phase PHASE2/PHASE3
NCT06286462 Evaluation of the Cancer Tracking System (CATSystem) Status ACTIVE_NOT_RECRUITING Phase NA
NCT06284031 Cervical Cancer Brachytherapy With Interstitial Needles in 3 Fractions Status RECRUITING Phase NA
NCT06276309 Protein Molecular Characteristics and Prognosis of Cervical Neuroendocrine Tumors Status RECRUITING Phase N/A
NCT06266338 Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix) Status RECRUITING Phase PHASE2